{
    "organizations": [],
    "uuid": "41aa9090c55134f13f37585c3e36cd37469a6284",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-chugai-pharmaceutical-says-waiver/brief-chugai-pharmaceutical-says-waiver-of-claims-in-patent-infringement-lawsuit-idUSL3N1RO31N",
    "ord_in_thread": 0,
    "title": "BRIEF-Chugai Pharmaceutical says waiver of claims in patent infringement lawsuit",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 11 (Reuters) - Chugai Pharmaceutical Co Ltd\n* Says it has decided to waive its claim in a patent infringement lawsuit against Nippon Kayaku Co Ltd\n* Says co filed a lawsuit to the Tokyo District Court on Aug. 17, 2017, demanding the suspension of manufacturing and distribution of the biosimilar of anti-HER2 monoclonal antibody Herceptin® Injection 60 and 150 (Herceptin® Injection) against Nippon Kayaku, the applicant for marketing approval of the biosimilar of Herceptin® Injection, citing such party’s infringement of the application patents for the treatment of breast cancer owned by Genentech Inc\nSource text in Japanese: goo.gl/7AQ1Qc\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-04-11T14:48:00.000+03:00",
    "crawled": "2018-04-12T14:14:47.021+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "chugai",
        "pharmaceutical",
        "co",
        "ltd",
        "say",
        "decided",
        "waive",
        "claim",
        "patent",
        "infringement",
        "lawsuit",
        "nippon",
        "kayaku",
        "co",
        "ltd",
        "say",
        "co",
        "filed",
        "lawsuit",
        "tokyo",
        "district",
        "court",
        "demanding",
        "suspension",
        "manufacturing",
        "distribution",
        "biosimilar",
        "monoclonal",
        "antibody",
        "injection",
        "injection",
        "nippon",
        "kayaku",
        "applicant",
        "marketing",
        "approval",
        "biosimilar",
        "injection",
        "citing",
        "party",
        "infringement",
        "application",
        "patent",
        "treatment",
        "breast",
        "cancer",
        "owned",
        "genentech",
        "inc",
        "source",
        "text",
        "japanese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}